Table 1.
Baseline characteristics of low-risk patients with and without initial SSS (n = 165).
| Characteristics | Overall n = 165 |
SSS Zero n = 74 |
SSS Positive n = 91 |
p-Value |
|---|---|---|---|---|
| Male Gender (n, %) | 121 (73.3%) | 59 (64.8%) | 62 (83.8%) | 0.008 |
| Age (y/o) | 58.5 ± 8.6 | 56.7 ± 8.8 | 60.8 ± 7.9 | 0.002 |
| BMI | 25.1 ± 3.1 | 24.8 ± 3.2 | 25.4 ± 2.9 | 0.197 |
| Hypertension (n, %) | 55 (34.8%) | 21 (23.9%) | 34 (48.6%) | 0.001 |
| Diabetes (n, %) | 16 (10.1%) | 4 (4.5%) | 12 (17.1%) | 0.015 |
| Dyslipidemia (n, %) | 46 (29.1%) | 22 (25.0%) | 24 (34.3%) | 0.221 |
| Smoking (n, %) | 51 (31.1%) | 29 (31.9%) | 22 (30.1%) | 0.866 |
| Drinking (n, %) | 71 (43.6%) | 40 (44.0%) | 31 (43.1%) | 1.000 |
| Cholesterol | 206.6 ± 38.3 | 209.8 ± 33.9 | 202.6 ± 42.9 | 0.226 |
| Triglyceride | 143.3 ± 80.5 | 143.9 ± 85.3 | 142.6 ± 74.9 | 0.914 |
| Uric acid | 6.5 ± 1.5 | 6.3 ± 1.4 | 6.8 ± 1.5 | 0.057 |
| HDL | 46.6 ± 13.4 | 48.0 ± 14.7 | 44.8 ± 11.5 | 0.128 |
| LDL | 129.9 ± 33.3 | 131.1 ± 31.3 | 128.4 ± 35.7 | 0.608 |
| Glucose | 98.8 ± 24.4 | 96.2 ± 20.7 | 101.9 ± 28.2 | 0.142 |
| AST | 25.9 ± 0.0 | 25.5 ± 0.0 | 26.4 ± 0.0 | 0.539 |
| ALT | 30.6 ± 0.0 | 31.3 ± 0.0 | 29.7 ± 0.0 | 0.569 |
| ALK-P | 64.0 ± 17.8 | 64.7 ± 16.6 | 63.2 ± 19.2 | 0.581 |
| Total bilirubin | 1.1 ± 0.5 | 1.1 ± 0.4 | 1.1 ± 0.5 | 0.931 |
| Direct bilirubin | 0.3 ± 0.1 | 0.3 ± 0.1 | 0.3 ± 0.1 | 0.857 |
| GGT | 33.0 ± 25.7 | 35.7 ± 29.2 | 29.5 ± 20.3 | 0.112 |
| LDH | 176.6 ± 51.1 | 173.2 ± 29.2 | 180.7 ± 69.1 | 0.350 |
| Albumin | 4.5 ± 0.2 | 4.5 ± 0.2 | 4.4 ± 0.3 | 0.342 |
| Total protein | 7.3 ± 0.5 | 7.3 ± 0.5 | 7.3 ± 0.5 | 0.673 |
| BUN | 12.9 ± 3.8 | 12.6 ± 3.6 | 13.3 ± 4.1 | 0.262 |
| Creatinine | 0.9 ± 0.2 | 0.9 ± 0.2 | 0.9 ± 0.2 | 0.111 |
| eGFR | 82.5 ± 12.1 | 82.9 ± 11.1 | 82.1 ± 13.3 | 0.675 |
| HsCRP | 0.2 ± 0.3 | 0.3 ± 0.4 | 0.2 ± 0.1 | 0.589 |
| CK | 95.7 ± 0.0 | 79.6 ± 0.0 | 115.3 ± 0.0 | 0.235 |
| Na | 141.3 ± 1.9 | 141.4 ± 2.0 | 141.1 ± 1.8 | 0.294 |
| K | 4.1 ± 0.3 | 4.1 ± 0.4 | 4.1 ± 0.3 | 0.389 |
| SBP | 122.8 ± 17.6 | 118.5 ± 17.7 | 128.0 ± 16.2 | 0.001 |
| DBP | 77.5 ± 10.4 | 75.6 ± 10.4 | 79.8 ± 9.9 | 0.010 |
| APRI | 0.3 ± 0.1 | 0.3 ± 0.1 | 0.3 ± 0.2 | 0.273 |
| Forns score | 4.9 ± 0.7 | 4.8 ± 0.6 | 5.0 ± 0.8 | 0.035 |
| FIB-4 | 1.3 ± 0.6 | 1.3 ± 0.5 | 1.4 ± 0.6 | 0.042 |
| NFS | −2.0 ± 1.1 | −2.2 ± 1.0 | −1.7 ± 1.1 | 0.003 |
| LVEF | 62.3 ± 7.0 | 61.1 ± 6.7 | 63.7 ± 7.0 | 0.033 |
| Baseline CAC | 12.9 ± 23.6 | 1.0 ± 5.0 | 27.5 ± 28.7 | <0.001 |
| Baseline SSS | 1.2 ± 2.0 | 0.0 ± 0.0 | 2.7 ± 2.2 | <0.001 |
BMI = body mass index, HDL = high-density lipoprotein, LDL = low-density lipoprotein, AST = aspartate transaminase, ALT = alanine aminotransferase, ALK-P = alkaline phosphatase, GGT= gamma-glutamyl transferase, LDH = lactate dehydrogenase, BUN = blood urea nitrogen, eGFR = estimated glomerular filtration rate, HsCRP = high-sensitivity C-reactive protein, CK = creatine kinase, SBP = systolic blood pressure, DBP = diastolic blood pressure, NFS = nonalcoholic fatty liver disease fibrosis score, FIB-4 = fibrosis-4 index, APRI = AST to platelet ratio index, LVEF = left ventricular ejection fraction, CAC = coronary artery calcium, SSS = segment stenosis score.